Choose Your Location:

Contact us

Press Releases

The following UK & Ireland Press Releases contain information that is intended for journalists only.
For media enquiries about our press releases please contact mediaenquiries.UK-IE@ipsen.com.

CRSC-GB-000136

April 2024


6 results

Ipsen appoints Ioana Parsons as General Manager, U.K. & ...
07 March 2024
__Plan de travail 3 copie 34@2x

LONDON, U.K., 6 March 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment…

See more

Ipsen Wrexham investment unveiled as Wrexham mayor joins 50t...
15 June 2023
__Plan de travail 3 copie 34@2x

WREXHAM, UK, 13 June 2023 – Ipsen today announced a £75 million investment in its…

See more

Ipsen’s response to NICE’s decision on Cabometyx® (cabozanti...
06 April 2023
__Plan de travail 3 copie 34@2x

SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health…

See more

NICE recommends Cabometyx® (cabozantinib) for previously tre...
10 November 2022
__Plan de travail 3 copie 34@2x

Cabozantanib has been recommended by NICE as an option for treating advanced hepatocellular carcinoma (HCC),…

See more

Tánaiste joins Ipsen Ireland to launch upgraded manufacturin...
04 October 2022
__Plan de travail 3 copie 34@2x

Dublin, Ireland, 25th/26th September 2022 Tánaiste joins Ipsen Ireland to launch upgraded manufacturing site in…

See more

Ipsen announced overall Pharma Industry Company of the Year ...
30 June 2022
__Plan de travail 3 copie 34@2x

Ireland, May 2022 Blanchardstown-based, biopharmaceutical Ipsen has been announced overall Pharma Industry Company of the…

See more
© Ipsen Group 2024